Navigation Links
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
Date:11/19/2008

h companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich Corporation and several companies applying its ZFP technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release contains forward-looking statements regarding Sangamo's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include the early stage of ZFP Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, and whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo will be able to develop commercially viable therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in Sangamo's operations and business environments. These risks and uncertainties are described more fully in Sangamo's' Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q as filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
2. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
3. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
4. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
5. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
6. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
7. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
8. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
10. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
11. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...OMAHA, Neb., Nov. 5 Tran...nounced financial results for the quarter ended Se...are presented in the tables that follow. ,, Th... loss of $366,000 or $0.01 per share for the third...,000 or $0.01 per share for the third quarter of 2...
(Date:11/5/2009)...SUNNYVALE, Calif., Nov. 5 /PRNewswire-FirstCall/ -...s executives will be speaking at the following inv...ipate via webcast. , , Credit Suis... Thursday, 12 November, 2009 at 10 a.m. Mounta... Program, London, England, Tuesday...
(Date:11/5/2009)...SAN DIEGO, CA, November 5, 2009 /PRNewswire-FirstC...focused on using proprietary taste receptor-based ...for the food, beverage, and ingredient supply indu...rted financial results for the third quarter ended...or the third quarter of 2009, compared to $4.0 mil...
(Date:11/5/2009)...AUSTIN, Texas, Nov. 5 SpineSmith P...teo, Inc. to co-develop a unique scaffold that mim...lowing evaluation of several commercial products b..., the company believes the GenOsteo scaffold repre... creates a unique and ideal environment for the de...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...take some of the blame for a number of societys il...ty. Through the morass of Grand Theft Auto and Max...ing game has emerged, an Oregon Trail for the 21st...Illinois, has developed Frontrunner, a computer ga... November of an election year. The game follows a ...
...nty has begun using a network infrastructure devel... to its workers over the Internet from a central o...ys IT staff will be able to provide 1,600 governme...ess to government and community management applica..., according to a press release. The technology has...
...s, Minn The two- and three-port Gigabit Ethernet ...de only for the Apple G5 platform have arrived for...ed company announced Monday. , ,"There are many mu...puter center these days," said Corky Seeber, Small...dware solution that can support Apple Mac OS, Wind...
Other Biology Technology:Political video game simulates 2004 election 2Political video game simulates 2004 election 3Dane County improves law enforcement and community services 2Small-Tree extends G5 networking platform to G4, Windows and Linux 2
(Date:11/4/2009)...RLSBAD, Calif., Oct. 23 GenVault C...ample management for genomic discovery, medicine a...is, Ph.D., GenVault,s President and CEO, will be p... place on October 26th and 27th in La Jolla, CA. ,...ide an overview of the company together with recen...
(Date:11/4/2009)... CHAPEL HILL Scientists at the University of Nort...he University of California, San Francisco have de...redict new target diseases for existing drugs. , ...that compares how similar the structures of all kn...artners -- known as ligands -- of disease targets ...
(Date:11/3/2009)...ON, WI, NOVEMBER 4, 2009 -- The world,s greatest ...grape variety, human input, and something called t...rd site, soil, and climate. , Experts will dis... symposium on Wednesday, Nov. 4 in Pittsburgh. "T...esented in two parts at the 2009 Annual Meetings o...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Study points to new uses, unexpected side effects of already existing drugs 2Great wines come from great soils 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 1Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 3Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 4Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 5Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 6Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 7Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 8HPV Vaccine Could Prevent Many Penile Cancers 55330 1HPV Vaccine Could Prevent Many Penile Cancers 55330 2Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 1Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 2
...rn mid- and upper-latitude regions are playing a s...iously thought, according to a study appearing in ... the so-called missing carbon sink, concludes that...dly high proportion of carbon dioxide from the atm...air through industrial emissions and deforestation...
...nce a comprehensive program against smoking was la... in the national Centers for Disease Control and P...(MMWR). The 2006 rate was nearly 20% lower than th...ewer smokers. The City’s rate for 2006 is the lowe...U.S. states (California, Washington, Idaho, Utah a...
...lking with a therapist or friend, writing in a jou... study by UCLA psychologists reveals why verbalizi...less intense. , Another study, with the same part...arch team, combines modern neuroscience with ancie...evidence for why “mindfulness” — the ability to li...
Other Biology News:Scientists close in on missing carbon sink 2Scientists close in on missing carbon sink 3Smoking rate has plummeted in New York City 2Putting feelings into words produces therapeutic effects in the brain 2Putting feelings into words produces therapeutic effects in the brain 3Putting feelings into words produces therapeutic effects in the brain 4Putting feelings into words produces therapeutic effects in the brain 5
...ting medium is specifically formulated for mountin...ch have been stained with immunohistochemical meth...or use with chromogens, such as AEC, that are alco... Faramount dries completely when slides are cover-...
...trieval Solution, High pH This pH 9.9 solution is...to immunohistochemical staining procedures. It is ...e sections mounted on glass slides. For particular...pecially effective. It should be noted that also e...
Dako Target Retrieval Solution, Citrate pH 6 (x 10) from Dako
Mouse Anti-Yersinia pestis F1 Antigen EB Strain Monoclonal Antibody, Unconjugated, Clone YPF19 from Meridian Life Science, Inc.
Biology Products: